http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150046520-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
filingDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20150046520-A |
titleOfInvention | Composition for the prevention or treatment of prostate-related diseases comprising Lambertianic acid derivative compound |
abstract | The present invention provides a composition for the prophylaxis or treatment of a prostate-related disease containing a lambertian acid derivative, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient . The composition according to the present invention exhibits an anti-androgen effect or a prostate-specific antigen-suppressing effect and is effective for the improvement, prevention and treatment of prostate-related diseases such as prostatitis, hyperplasia of the prostate, and prostate cancer. |
priorityDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.